Memory and Aging Center Grand Rounds

Neuroimaging and Neuropathological Investigations of Alzheimer's Disease Clinical and Biological Heterogeneity

Renaud La Joie, PhD
Assistant Professor of Neurology
University of California, San Francisco

Learning Objectives

• Describe different dimensions of Alzheimer's disease clinical heterogeneity.
• Relate clinical features to imaging and neuropathological markers.
• Discuss the relevance of biomarkers to guide diagnosis and treatment.

Disclosures

• Planners: Bruce L. Miller, MD; Howard J. Rosen, MD; Kaancan Deniz, MD; Anil Vora; and Janet Allen-Williams have stated they have no relationships to disclose.
• Speaker: Renaud La Joie, PhD, has disclosed the following relationships: Associate Editor for Alzheimer's Research & Therapy and consulted for GE Healthcare.

Accreditation: The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation: UCSF designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit is inclusive of all Memory and Aging Center Grand Rounds sessions offered from January 1, 2024, through December 31, 2024. (1 credit per each 1-hour grand rounds session throughout the year).

Attendees must register for this event. Grand Rounds presentations are for educational purposes and intended for a professional audience with a terminal degree. This activity is not commercially supported.